Alkaline Phosphatase Isoenzymes
Alkaline phosphatase (ALP) belongs to a category of enzymes that primarily catalyze removal of phosphate esters. The enzyme is found in many tissues and is especially concentrated in the liver, bile duct, intestine, kidney, bone, and placental tissue. In a number of these tissues, the molecular form of the enzyme is distinctive, and isoenzyme evaluation can offer additional information to identify the cause of increased ALP levels. ALP is synthesized by biliary epithelium and excreted in bile. It is called alkaline since it functions only at alkaline pH. More than 80% of this enzyme activity originates from liver and bone. Increased serum ALP levels provide a useful but nonspecific indication of liver or bone disease. ALP levels increase with obstructed biliary excretion. Increased levels are also seen in hepatic and bone metastases. However, ALP levels are increased in normal physiological processes as well as bone growth and fracture healing. ALP levels can be increased with alcohol use and in some inflammatory processes and pregnancy.
To determine the origin of elevated ALP, isoenzymes by electrophoresis should be ordered. There are several ALP isoenzymes. Differentiation of isoenzymes is important for differential diagnosis, and especially to differentiate between physiological inflammatory and pathological conditions. These are the most common tested enzymes: liver, bone, intestinal and placental isoenzymes.
Liver Isoenzymes
There are two liver isoenzymes, L1 and L2.
- L1 can be increased in some non-malignant diseases such as cholestasis, cirrhosis, viral hepatitis and in various biliary and hepatic pathologies. It can also be increased in malignancies with hepatic metastasis, in cancer of the lungs and digestive tract, and in lymphoma.
- L2, also called macrohepatic or fast liver, also exists in healthy subjects but at lower concentration than L1. It can be increased in cholestasis and biliary diseases (such as cirrhosis, viral hepatitis) and in liver metastases (such as breast, lung, prostate, digestive tract).
Bone Isoenzyme
The bone isoenzyme has to be interpreted with respect to the patient’s age because its elevation is physiologically normal during growth phases of life. Increase of the fraction may be associated with the following conditions: malignancies with bone metastasis, osteosarcoma, lymphoma, rheumatismal diseases, hyperparathyroidism, Paget’s disease, and rickets.
Intestinal Isoenzyme
Intestinal isoenzymes are often found in individuals with blood types O and B. Its increase may be associated with liver cirrhosis, diabetes, and chronic renal failure.
Placental Isoenzyme
Placental isoenzymes are found in pregnancy and begin rising late in the first trimester. They continue to rise up to one month after the termination of pregnancy. These enzymes are also associated with malignant diseases such as ovarian cancer, sarcomas, pancreatic cancers, and stomach cancers. An increase can also be seen in heavy smokers.
- To differentiate between physiological and pathological conditions in young men (especially between bone growth and bone disease)
- In diagnosis of liver cancer, metastasis, and biliary obstruction
- Diagnosis of bone disease and metastasis
- It is used as a tumor marker for indication of tumor origin such as leukemia, myelofibrosis, carcinoma of the head of pancreas, and osteogenic sarcomas
- Aid in detection of bone metastasis from prostate and breast carcinoma
Increased in:
- Obstructive hepatobiliary disease
- Bone disease
- Physiologic bone growth
- Paget’s disease
- Osteomalacia
- Osteogenic sarcoma
- Bone metastases
- Some gynecologic malignancies
- Hyperparathyroidism
- Secondary hyperparathyroidism
- Rickets
- Benign familial hyperphosphatemia
- Pregnancy (third trimester)
- Sarcoidosis
- Sepsis
- Congestive heart failure
- Certain viral infections (CMV, Infectious mononucleosis)
- GI disease (perforated ulcer or bowel infarct)
- Some hepatotoxic drugs
Decreased in:
- Hypophosphatasia
Electrophoresis, HPLC MS.
Serum (SST).
Stability
- Ambient: 72 hours
- Refrigerated: 72 hours
- Frozen: 60 days
- Freeze immediately and maintain frozen until tested.
2-5 days.
- Indian J Pediatr. 2007 Jul;74(7):663-71. [PMID: 17699976]
- Clin Lab Med. 2002;22:377. [PMID: 12134466]
- Endocr Pract. 2006;12:676. [PMID: 17229666]
- Pediatr Rev. 2006;27:382. [PMID: 17012488]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757